The 2011-2016 Outlook for Anti-Migraine Drugs in Greater China
This econometric study covers the latent demand outlook for anti-migraine drugs across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as "regions"). Latent demand (in millions of U.S. dollars), or
No comments:
Post a Comment